Blink Stock Scales the Nasdaq for Second Time In Two Weeks

The FDA rejected Evolus' rival Botox drug, sending the Wall Street rookie reeling

by Patrick Martin

Published on May 16, 2018 at 2:58 PM

Stocks are climbing today, thanks to encouraging retail earnings. Among stocks making particular noise today, chip name Micron Technology, Inc. (NASDAQ:MU) and penny stock Blink Charging Co (NASDAQ:BLNK) are pushing higher, while drug stock Evolus Inc (NASDAQ:EOLS) is gapping lower. Here's a closer look at what has shares of MU, BLNK, and EOLS moving today.

Bullish Brokerage Note Lifts Micron Stock

Micron Technology stock, along with sector peer Advanced Micro Devices (AMD), is higher after some bullish analyst attention today, up 4.5% to trade at $56.43. RBC initiated coverage on the chip stock with an "outperform" rating and $80 price target -- a 42% premium to the equity's current price. Analyst Amit Daryanani said Micron offers "a unique way for investors to gain exposure to the DRAM and NAND markets" at an attractive valuation.

In addition, traders are digesting the latest hedge fund disclosures. Appaloosa upped its stake in Micron by nearly 29% last quarter, while Omega Advisors initiated a stake. MU shares have now added more than 10% in the past week, and have almost doubled in the past year, with pullbacks contained by support from their 160-day moving average.

Options traders have demonstrated bearish tendencies of late, however. Micron's Schaeffer's put/call open interest ratio (SOIR) of 0.73, which ranks higher than 96% of all comparable readings taken in the past year. Simply stated, options traders are more put-heavy than usual among contracts set to expire in three months or less.

Earnings Report Powers Blink Stock to Top of Nasdaq

Blink stock is up 34.8% to trade at $7.35 -- the best stock on the Nasdaq today -- after the company said it swung to a profit in the first quarter, after reporting a loss a year ago. This would mark the second time in two weeks that Blink stock raced to the top of the Nasdaq.

BLNK shares have now added 50% in the past week, and have nearly filled their early-February bear gap. Since falling to a record low of $1.28 on April 26, the security has gained 474%. Shorts have begun jumping ship amid this meteoric rally, with short interest falling by nearly 20% in the most recent reporting period.

FDA Rejection Guts Evolus Stock

Evolus stock is down 23.5% to trade at $11.21 -- one of the worst stocks on the Nasdaq today -- after the biotech's rival treatment to Botox was rejected by the Food and Drug Administration (FDA). In response, Mizuho slashed its price target to $16 from $21.

EOLS stock is on pace for its worst single-day performance ever, yet remains far off its record low of $6.75, tagged just April 30. The shares are now back below their February IPO price of $12. Analysts remain committed to the biotech, though. All four of the brokerages covering EOLS rate it a "strong buy," and its average 12-month price target of $21.25 is nearly double its current price. 

Semiconductor Sell-Off Could be Good News for This Chip Stock
Pullbacks to the 320-day moving average have marked buying opportunities
Time To Bet On a Netflix Stock Rally
The shares are trading near a trendline that has historically bullish implications
Molina Healthcare Stock Could Make a Big Move Higher
A "buy" signal is flashing for MOH again
From Schaeffer's Pro Traders
Weekly Options Secrets Revealed

Direct from our Schaeffer's traders, your FREE guide to winning with weekly options!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?
Amedisys Carves Out New Highs on Oppenheimer's Latest Hike
AMED nabbed another new record high earlier today
Walmart Earnings, Tesla Share Spotlight With Turkey, Trade
The retailer's earnings have the Dow headed toward a weekly win
The Tax Plan is Never Going to Grow the Economy… Unless This Is Fixed First
Are you ready for a potential economic reset?